Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 22,000 shares at $454.15 ($9.9M) on 2025-10-30, disclosed to the SEC on 2025-10-30.
Scheduled sale ($9.9M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $447.34 | 642 | $287K | 2.9% |
| 2 | $447.34 | 642 | $287K | 2.9% |
| 3 | $448.56 | 1,143 | $513K | 5.2% |
| 4 | $448.56 | 1,143 | $513K | 5.2% |
| 5 | $449.46 | 3,441 | $1.5M | 15.6% |
| 6 | $449.46 | 3,441 |
| $1.5M |
| 15.6% |
| 7 | $450.64 | 2,247 | $1.0M | 10.2% |
| 8 | $450.64 | 2,247 | $1.0M | 10.2% |
| 9 | $451.57 | 1,849 | $835K | 8.4% |
| 10 | $451.57 | 1,849 | $835K | 8.4% |
| 11 | $452.33 | 1,285 | $581K | 5.9% |
| 12 | $452.33 | 1,285 | $581K | 5.9% |
| 13 | $454.15 | 393 | $178K | 1.8% |
| 14 | $454.15 | 393 | $178K | 1.8% |
| Total | $450.34 avg | 22,000 | $9.9M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |